Abstract:Purpose: To investigate the contribution of the gut microbiota to the pathogenesis of uveitis. Methods: Experimental autoimmune uveitis (EAU) in B10.RIII mice was induced using interphotoreceptor binding protein peptide. Mice were treated with oral or intraperitoneal (IP) antibiotics. Effector (Teff) and regulatory (Treg) T lymphocytes were identified using flow cytometry; 16S rRNA gene sequencing and qPCR were performed on gastrointestinal (GI) contents. Results: Broad-spectrum (four antibiotics given simultaneously) oral, but not IP, antibiotics reduced mean uveitis clinical scores significantly compared with water-treated animals (0.5 vs. 3.0, P < 0.0001 for oral; 3.4 vs. 3.4, P > 0.99 for IP). Both oral metronidazole (P = 0.02) and vancomycin (P < 0.0001) alone decreased inflammation, whereas neomycin (P = 0.7) and ampicillin (P = 0.4) did not change mean uveitis scores. Oral broad-spectrum antibiotics increased Tregs in the GI lamina propria of EAU animals at 1 week, and in extraintestinal lymphoid tissues later, whereas Teff and inflammatory cytokines were reduced. 16S sequencing of GI contents revealed altered microbiota in immunized mice compared with nonimmunized mice, and microbial diversity clustering in EAU mice treated with uveitis-protective antibiotics. Experimental autoimmune uveitis mice also demonstrated gut microbial diversity clustering associated with clinical score severity. Conclusions: Oral antibiotics modulate the severity of inducible EAU by increasing Tregs in the gut and extraintestinal tissues, as well as decreasing effector T cells and cytokines. 16S sequencing suggests that there may be protective and, conversely, potentially uveitogenic, gut microbiota. These findings may lead to a better understanding of how uveitis can be treated or prevented by modulating the gut microbiome.

Microbiota-Dependent Activation of an Autoreactive T Cell Receptor Provokes Autoimmunity in an Immunologically Privileged Site

Gut microbiota as a source of signals that trigger spontaneous ocular autoimmunity.

Gut microbiota as a source of a surrogate antigen that triggers autoimmunity in an immune privileged site

Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a transgenic T cell receptor specific for a retinal autoantigen

Microbiome and Autoimmune Uveitis

An Experimental Autoimmune Uveoretinitis Model and Intraocular Inflammation

Human gut commensals support development of ocular autoimmunity in retina-specific T cell receptor transgenic mice

Spontaneous Ocular Autoimmunity in Mice Expressing a Transgenic T Cell Receptor Specific to Retina: A Tool to Dissect Mechanisms of Uveitis

Regulation of Autoimmunity by the Microbiome

Quantitative Characterization Of Autoimmune Uveoretinitis In An Experimental Mouse Model

[The Function and Changes of Immune Cells in Autoimmune Uveitis].

Association of gut microbiota with spontaneous autoimmune uveitis studied by human flora reconstitution of germ-free mice

Exposure of autoimmune uveitis-prone germ-free mice to commensal microbiota promotes development of ocular inflammation

Retinal microglia exacerbate uveitis by functioning as local antigen-presenting cells

Gut Microbial Alterations Associated With Protection From Autoimmune Uveitis

The living eye "disarms" uncommitted autoreactive T cells by converting them to Foxp3(+) regulatory cells following local antigen recognition.

Characterization of Clinical and Immune Responses in an Experimental Chronic Autoimmune Uveitis Model

Induction of Antigen-Specific Treg Cells in Treating Autoimmune Uveitis Via Bystander Suppressive Pathways Without Compromising Anti-Tumor Immunity

Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitis

Retina-Specific T Regulatory Cells Bring about Resolution and Maintain Remission of Autoimmune Uveitis

Human autoreactive T cells recognize CD1b and phospholipids